NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/09/2025
Voltar para busca
Dado oficial do USPTO
ONCOBODIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ONCOBODIES
ST13
US500000079368859Classe
1, 5, 42, 44
Pedido
79368859
Registro
7376665
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
20/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
02/02/2023
Data de registro
07/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/05/2024
Última transação
20/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
NL
Examinador
VAGHANI, MAYUR
Unidade examinadora
N60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
LinXis B.V.
Representantes
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals; carrier excipients for use in the manufacture of pharmaceutical preparations
Classe 5
Drug delivery agents in the form of powderstablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biochemical medicines for the treatment of cancer; chemical preparations for pharmaceutical purposesfor the treatment of cancer; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of cancer
Classe 42
Pharmaceutical research services; scientific research in the nature of conducting clinical trials for pharmaceuticals for others; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; research services in the field of proteinsantibodiesmicroorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
Classe 44
In vitro analysis for medical and pharmaceutical useanalysis for medical diagnostic or treatment purposes; in vitro testing for medical and pharmaceutical usetesting for medical diagnostic or treatment purposes; consultancy and information services provided via the Internet relating to pharmaceutical productsnamely pharmaceutical consultation
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
14/03/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/11/2024
FIMP
FINAL DISPOSITION PROCESSED
04/11/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
20/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
27/02/2024
PUBO
PUBLISHED FOR OPPOSITION
20/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/12/2023
RFNP
REFUSAL PROCESSED BY IB
28/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2023
RFRR
REFUSAL PROCESSED BY MPU
07/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/11/2023
CNRT
NON-FINAL ACTION WRITTEN
06/11/2023
DOCK
ASSIGNED TO EXAMINER
01/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOBODIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.